Hypermetropia
11
0
2
2
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
18.2%
2 terminated out of 11 trials
50.0%
-36.6% vs benchmark
18%
2 trials in Phase 3/4
100%
2 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (11)
The Emmetropization Via Accommodation (EVA) - II Study
Treatment of Residual Hypermetropic Refraction on Pseudophakic Patients Using Allogenic Fresh Myopic Lenticule
Safety and Suitability of ICL for Correction of Refractive Errors Without the Use of Dispersive OVDs
Comparison Between Myopia Versus Hypermetropia With Progressive Addition Lenses in Computer Users
Use of a Disk of Amniotic Membrane (Visio-AMTRIX) in Postoperative Care After PKR
Anesthetic Impregnated Bandage Soft Contact Lens (BSCL) in Pain Management After Photorefractive Keratectomy (PRK)
Use of the VisuMax Femtosecond Laser Lenticule Removal Procedure for the Correction of Hyperopia
Clinical Assessment of a HYDRAGLYDE® Regimen
Randomized, Non-inferiority Trial Comparing SMILE and LASIK
Enhancement of Emmetropization in Hyperopic Infants
Ocular Imaging With Spectral Domain Optical Coherence Tomography